RE: White House Launching $5Bn Program To Speed Coronavirus Vaccines and Therapies12 Apr 2023 17:43
Size82 - respectfully, I have to disagree. We had a market cap of £400m. If we say we had a 50/50 chance of passing P3 (it really should have been higher), I'd argue we had a 50% chance of losing £400m but the rewards would have been much greater had we passed. The only properly trialled, variant agnostic Covid therapeutic, that also had a different method of delivery. Covid was also still rife.
Companies with successful P3 drugs also go for much more than £400m.
I will say that the rewards have potentially diminished and in fact, I don't think SNG would see another trial to the end, but if we land another P3 trial, we should be well north of 9p. Best guess, cos Aether loves a prediction...(!) 50-80p, drifting back up towards 100p+.